Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1061-1070 of 1,421) with videos related to

Pageof 143
Sort By:
Pharmacoepidemiology and Drug Safety|March 14, 2007
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) studyF Depont, A Fourrier, Y Merlière, et al.
Brain and Language|July 27, 2010
Functional anatomy of listening and reading comprehension during developmentMadison M Berl, Elizabeth S Duke, Jessica Mayo, et al.
Frontiers in Cardiovascular Medicine|December 23, 2021
The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6Heather A Cole, Stephanie N Moore-Lotridge, Gregory D Hawley, et al.
BMC Cancer|July 3, 2013
Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental modelsOleksandr Ekshyyan, Tara N Moore-Medlin, Matthew C Raley, et al.
Future Oncology (London, England)|July 6, 2022
Niraparib treatment for patients with <i>BRCA</i>-mutated ovarian cancer: review of clinical data and therapeutic contextAntonio González-Martín, Ursula A Matulonis, Jacob Korach, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2024
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.
Cardio-Oncology (London, England)|July 27, 2025
The cardio-oncology multidisciplinary team: beyond the basicsJoshua D Bennetts, Trent D Williams, Craig J Beavers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.
The Science of the Total Environment|October 6, 2020
Antagonistic cytoprotective effects of C<sub>60</sub> fullerene nanoparticles in simultaneous exposure to benzo[a]pyrene in a molluscan animal modelMichael N Moore, Susanna Sforzini, Aldo Viarengo, et al.
Tissue Engineering. Part A|October 23, 2018
Hypoxia and TGF-β3 Synergistically Mediate Inner Meniscus-Like Matrix Formation by FibrochondrocytesAlexander R A Szojka, Brayden D Lyons, Colleen N Moore, et al.
Pageof 143

Showing results (1061-1070 of 1,421) with videos related to

Sort By:
Pageof 143
Pharmacoepidemiology and Drug Safety|March 14, 2007
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) studyF Depont, A Fourrier, Y Merlière, et al.
Brain and Language|July 27, 2010
Functional anatomy of listening and reading comprehension during developmentMadison M Berl, Elizabeth S Duke, Jessica Mayo, et al.
Frontiers in Cardiovascular Medicine|December 23, 2021
The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6Heather A Cole, Stephanie N Moore-Lotridge, Gregory D Hawley, et al.
BMC Cancer|July 3, 2013
Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental modelsOleksandr Ekshyyan, Tara N Moore-Medlin, Matthew C Raley, et al.
Future Oncology (London, England)|July 6, 2022
Niraparib treatment for patients with <i>BRCA</i>-mutated ovarian cancer: review of clinical data and therapeutic contextAntonio González-Martín, Ursula A Matulonis, Jacob Korach, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2024
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.
Cardio-Oncology (London, England)|July 27, 2025
The cardio-oncology multidisciplinary team: beyond the basicsJoshua D Bennetts, Trent D Williams, Craig J Beavers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.
The Science of the Total Environment|October 6, 2020
Antagonistic cytoprotective effects of C<sub>60</sub> fullerene nanoparticles in simultaneous exposure to benzo[a]pyrene in a molluscan animal modelMichael N Moore, Susanna Sforzini, Aldo Viarengo, et al.
Tissue Engineering. Part A|October 23, 2018
Hypoxia and TGF-β3 Synergistically Mediate Inner Meniscus-Like Matrix Formation by FibrochondrocytesAlexander R A Szojka, Brayden D Lyons, Colleen N Moore, et al.
Pageof 143